Literature DB >> 23637309

The molecular basis of β-thalassemia.

Swee Lay Thein1.   

Abstract

The β-thalassemias are characterized by a quantitative deficiency of β-globin chains underlaid by a striking heterogeneity of molecular defects. Although most of the molecular lesions involve the structural β gene directly, some down-regulate the gene through distal cis effects, and rare trans-acting mutations have also been identified. Most β-thalassemias are inherited in a Mendelian recessive fashion but there is a subgroup of β-thalassemia alleles that behave as dominant negatives. Unraveling the molecular basis of β-thalassemia has provided a paradigm for understanding of much of human genetics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637309      PMCID: PMC3633182          DOI: 10.1101/cshperspect.a011700

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  102 in total

1.  Molecular characterization of a novel 10.3 kb deletion causing beta-thalassaemia with unusually high Hb A2.

Authors:  J E Craig; S J Kelly; R Barnetson; S L Thein
Journal:  Br J Haematol       Date:  1992-12       Impact factor: 6.998

2.  A novel globin structural mutant, Showa-Yakushiji (beta 110 Leu-Pro) causing a beta-thalassemia phenotype.

Authors:  Y Kobayashi; Y Fukumaki; N Komatsu; Y Ohba; T Miyaji; Y Miura
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

3.  The Corfu delta beta thalassaemia mutation in Greece: haematological phenotype and prevalence.

Authors:  J Traeger-Synodinos; M Tzetis; E Kanavakis; A Metaxotou-Mavromati; C Kattamis
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

4.  A beta-thalassaemia phenotype not linked to the beta-globin cluster in an Italian family.

Authors:  S Murru; G Loudianos; S Porcu; G V Sciarratta; S Agosti; M I Parodi; A Cao; M Pirastu
Journal:  Br J Haematol       Date:  1992-06       Impact factor: 6.998

5.  Dominant beta-thalassaemia trait in a Portuguese family is caused by a deletion of (G)TGGCTGGTGT(G) and an insertion of (G)GCAG(G) in codons 134, 135, 136 and 137 of the beta-globin gene.

Authors:  R Oner; C Oner; J B Wilson; G P Tamagnini; L M Ribeiro; T H Huisman
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

6.  A spontaneous deletion of beta 33/34 Val in exon 2 of the beta globin gene (Hb Korea) produces the phenotype of dominant beta thalassaemia.

Authors:  S S Park; R Barnetson; S W Kim; D J Weatherall; S L Thein
Journal:  Br J Haematol       Date:  1991-08       Impact factor: 6.998

7.  A novel mutation (nonsense beta 127) in exon 3 of the beta globin gene produces a variable thalassaemic phenotype.

Authors:  G W Hall; I M Franklin; T Sura; S L Thein
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

8.  Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the beta-globin gene.

Authors:  H H Kazazian; C E Dowling; R L Hurwitz; M Coleman; A Stopeck; J G Adams
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

9.  A case of hemoglobin Indianapolis [beta 112(G14) Cys----Arg] in an individual from Cordoba, Spain.

Authors:  M Baiget; C Gomez Pereira; D L Jue; M H Johnson; J E McGuffey; W F Moo-Penn
Journal:  Hemoglobin       Date:  1986       Impact factor: 0.849

10.  Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA.

Authors:  C Wong; C E Dowling; R K Saiki; R G Higuchi; H A Erlich; H H Kazazian
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

View more
  79 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 2.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 3.  RNA Splicing and Disease: Animal Models to Therapies.

Authors:  Matías Montes; Brianne L Sanford; Daniel F Comiskey; Dawn S Chandler
Journal:  Trends Genet       Date:  2018-11-19       Impact factor: 11.639

Review 4.  Classification of the disorders of hemoglobin.

Authors:  Bernard G Forget; H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

5.  Ocular findings in children with thalassemia major in Eastern Mediterranean.

Authors:  Adnan Aksoy; Murat Aslankurt; Lokman Aslan; Ozlem Gül; Mesut Garipardıç; Oğuz Celik; Seydi Okumuş; Murat Ozdemir; Gökhan Ozdemir
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

6.  Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy.

Authors:  Lee Spraggon; Luca Cartegni
Journal:  Drug Discov Today Ther Strateg       Date:  2013

7.  Red Cell Indices in Screening of Thalassemia Trait During Antenatal Period.

Authors:  Ravindra Kumar; Rajasubramaniam Shanmugam
Journal:  J Obstet Gynaecol India       Date:  2019-08-22

Review 8.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 9.  Iron deficiency anemia: a common and curable disease.

Authors:  Jeffery L Miller
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 10.  Hemoglobin genetics: recent contributions of GWAS and gene editing.

Authors:  Elenoe C Smith; Stuart H Orkin
Journal:  Hum Mol Genet       Date:  2016-06-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.